Tech Company Financing Transactions
Edison Pharmaceuticals Funding Round
Edison Pharmaceuticals, operating out of Mountain View, received $50 million in investment from private investors.
Transaction Overview
Company Name
Announced On
3/28/2014
Transaction Type
Venture Equity
Amount
$50,000,135
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
350 North Bernardo Ave.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guy Miller
Chief Medical Officer
Matthew Klein
VP - Manufacturing
Peter Giannousis
VP - R & D
Kerstin Leuther
Browse more venture capital transactions:
Prev: 3/28/2014: HealthQx venture capital transaction
Next: 3/28/2014: Coinsetter venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs